Decreased Exhaled Nitric Oxide in Mild Persistent Asthma Patients Treated with a Leukotriene Receptor Antagonist, Pranlukast
| Autor: | Ryuji Hataishi, Tomoyuki Tomita, Hisashi Mitsufuji, Naohiko Tanaka, Tailin Cui, Hirosuke Kobayashi, Yuko Takahashi, Tadashi Kawakami |
|---|---|
| Rok vydání: | 1999 |
| Předmět: |
Adult
Male Physiology Corticosteroid treatment Pharmacology Nitric Oxide Pranlukast Nitric oxide chemistry.chemical_compound Humans Medicine Anti-Asthmatic Agents Receptors Leukotriene Leukotriene receptor business.industry Antagonist Healthy subjects General Medicine Middle Aged Asthma chemistry Chromones Exhaled nitric oxide Leukotriene Antagonists Female business Mild persistent asthma medicine.drug |
| Zdroj: | The Japanese Journal of Physiology. 49:541-544 |
| ISSN: | 0021-521X |
| DOI: | 10.2170/jjphysiol.49.541 |
| Popis: | Exhaled nitric oxide (NO) level decreases after corticosteroid treatment in asthmatics, but the effect of a leukotriene receptor antagonist, pranlukast, on exhaled NO has not been elucidated. Pranlukast treatment in mild persistent asthmatics for 4 weeks decreased the exhaled NO level, which did not differ from the levels in healthy subjects. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|